Lyrebird Health, founded in 2023, has rapidly established itself as Australia's most widely used AI medical scribe - a distinction earned in an extraordinarily short timeframe. The company's platform securely listens during clinical consultations and generates accurate, comprehensive clinical notes tailored to each clinician's individual documentation style. It supports the full scope of administrative tasks for healthcare practices, including clinical notes, documents, letters, certificates, and care plans, serving over 28,000 patients through its platform.
The company operates across three major healthcare markets: Australia, the United Kingdom, and the United States. Its technical work spans AI, medical scribing, clinical documentation, and data security - domains that demand both engineering rigour and deep domain expertise. Lyrebird Health's commitment to data security is a defining operational principle: all data processing occurs onshore, protected by bank-level encryption, and customer data is never used to train external AI models.
For engineers and technical professionals, Lyrebird Health represents an opportunity to work on applied AI in a domain where accuracy and trust are non-negotiable. The pace of adoption - achieving market leadership within two years of founding - suggests a product that solves a genuine and pressing problem for clinicians burdened by administrative overhead.
